“Persistence, Clinical and Economic Impact of Infliximab CT-P13 in Rheumatoid Arthritis, Psoriatic Arthropathy and Ankylosing Spondylitis Naïve and Switched Patients: After 5 Years of Follow-Up”. Journal of Pharmacy and Nutrition Sciences , vol. 12, Dec. 2022, pp. 74-79, https://doi.org/10.29169/1927-5951.2022.12.06.